课题基金 / 基金详情

Implementing a novel multimode 3D retinal imaging system to investigate metabolism and vascular disruptions in diabetic retinopathy

Implementing a novel multimode 3D retinal imaging system to investigate metabolism and vascular disruptions in diabetic retinopathy
实施新型多模式 3D 视网膜成像系统来研究糖尿病视网膜病变的代谢和血管破坏
批准号:
10349947
负责人:
Mahsa Ranji
金额:
$34.62万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-06-01 至 2024-05-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Diabetes causes microvascular and cellular redox complications in the retina and development of diabetic retinopathy (DR). The early mechanisms by which diabetes adversely affects retinal neurovascular function and integrity, and diabetic retinopathy progression, are poorly understood. This lack of understanding is hampered by the inability to detect and study these changes early and non-invasively. There is a crucial need for noninvasive imaging tools and quantitative biomarkers as indicators of diabetes’ adverse effect on the retinal neurovasculature, metabolism, and function. The main premise of this study is addressing the significant gap in existing tools to simultaneously and noninvasively measure mitochondrial redox state, and retinal neurovascular integrity during diabetes. These measurements will provide biomarkers, which could be used in primary care settings. The main hypothesis of this AREA project is that diabetes stimulates mitochondrial dysfunction, increased OxS, and neurovascular disruption in the retina that can be detected non-invasively. Our team will implement a MM- cSLO to evaluate these changes in diabetic Akita/+ mice to test that early disruption of mitochondrial redox states and neurovascular integrity is critical in retinal dysfunction. There are three specific aims to test these hypotheses.1) Design and implement a multimodal confocal scanning laser ophthalmoscope (MM-cSLO) for high resolution spatiotemporal imaging of DR biomarkers. 2) Determine changes in the retinal vascular network, oxygenation, and mitochondrial dysfunction during diabetes. The outcome of these studies will establish the course of mitochondrial dysfunction and neurovascular disruption in early diagnosis of diabetes changes. The use of this non-invasive imaging modality could permit detection and treatment of patients with diabetes based upon individualized risk versus benefit assessments in real time. Correlation of anatomical and functional information from retinal imaging could help elucidate the functional consequences of the findings of retinal imaging and provide further support for their use as outcomes measures of therapeutic intervention. If these detection and treatment methods are proven effective, they could be immediately evaluated in translational research. This AREA application will lead to a unique interdisciplinary educational platform for training UWM undergraduate and graduate students. There is a very broad and very rich educational opportunity for students to learn about electronics, optics, instrumentation, biology, biochemistry, computer programing wrapped in specific research project that can only be accomplished in such an interdisciplinary approach. Such an educational platform would increase the participation of UWM’s undergraduates majoring in electrical engineering and biomedical engineering in research. Successful implementation of these research activities will facilitate the long term, sustainable goal of translation from bench side to clinical bedside.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
Novel-miR-1134调控LHCGR的表达介导拟 穴青蟹卵巢发育的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    崔文晓
  • 依托单位:
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
  • 批准号:
    82304677
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    边兴博
  • 依托单位:
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
  • 批准号:
    82304658
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    刘亚
  • 依托单位:
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
  • 批准号:
    32102747
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2021
  • 负责人:
    李婉雁
  • 依托单位: